Gitelman's syndrome is an autosomal recessive disorder characterized by sodium wasting and hypotension. A middle-aged woman was diagnosed with Gitelman's syndrome because of typical clinical manifestations in the youth and homozygous mutations of 18-base-pair insertion in exon 6 of thiazide-sensitive NaCl-cotransporter gene. It was unusual that she showed hypertension with advancing age. Her serum potassium levels remained low at around 3.5 mEq/l despite potassium supplementation. This case demonstrates that hypertension could result in spite of the extremely decreased sodium reabsorption in Gitelman's syndrome and that essential hypertension is genetically heterogeneous, and abnormality of all genes may not be necessarily required to cause blood pressure rise.
Introduction
Gitelman's syndrome is an autosomal recessive disorder characterized by sodium wasting and low blood pressure. [1] [2] [3] Recently, we have experienced an unusual case of Gitelman's syndrome which manifested as hypertension in middle age.
Gitelman's syndrome is caused by homozygous or compound heterozygous inactivating mutations in the thiazide-sensitive NaCl-cotransporter (TSC) gene, leading to a reduction in renal sodium reabsorption. To date, several compound heterozygous mutations in the TSC gene such as Gly439Ser, Gly731Arg, Gly741Arg, Thr304Pro, and 2745insAG-CA, have been reported, and these mutations cause loss of function of the thiazide-sensitive NaCl-cotransporter (TSC) and reduce its capability to reabsorb salt in the distal renal tubules. 4 Here we describe a case of typical Gitelman's syndrome, caused by homozygous mutation of the TSC gene, who developed hypertension during middle age.
Case report
A 38-year-old woman was firstly diagnosed and reported in 1982 as a case of familial Bartter's syndrome (one of sisters with hypokalemia, hyperreninemia, normal blood pressure, and decreased pressor response to angiotensin II). 5 She was reevaluated recently and concluded to have Gitelman's syndrome by gene analysis.
To detect the genetic mutation, direct sequencing analysis was conducted for all 26 exons of the TSC gene. In exon 6, an 18-base insertion was found homozygously, which was the repeated sequence just before the 18 bp insertion. This mutation has already been reported in a compound heterozygous case; 6 however, this is the first reported case of homozygous type.
She was followed up with potassium supplementation (slow-K s 6-12 tablets: 48-96 mEq/day) for 19 years. At the age of 55 years, she underwent surgery for breast cancer and received oral anticancer treatment for 2 years (5-fluorouracil and tamoxifen) until her death from metastatic breast cancer. During the follow-up course, her blood pressure increased gradually with advancing age. Her blood pressure was relatively low, around 100/ 60 mmHg, when she was initially diagnosed with familial Bartter's syndrome at the age of 38 years. 5 Blood pressure was 120-135/70-84 mmHg at the age of 40-52 years and increased to 138-148/75-84 mmHg at 53-55 years, and further increased to 150-174/76-90 mmHg at 56-57 years. The renal function had been normal and plasma renin activity had been high all her life after diagnosed with familial Bartter's syndrome; 'creatinine level was 0.5-0.7 mg/dl, creatinine clearance was 90 ml/min/ m 2 at 38 years old and 89 ml/min/m 2 at 57 years old' (Figure 1 ).
Her serum potassium levels remained low at around 3.5 mEq/ l despite potassium supplementation. Body weight did not change at about 60 kg (body mass index ¼ 26.7 kg/m 2 ), and it seemed unlikely that the chemotherapy had any effect on the tendency for increasing blood pressure.
Discussion
Gitelman's syndrome is an inherited disease characterized by hypokalemia, hypocalciuria, and caused by compound heterozygous or homozygous TSC gene mutations. The blood pressure of this disease is normal or low (90-110/60-70 mmHg). 6, 7 Moreover, subjects with heterozygous mutation have lower blood pressure (À8.7 mmHg in diastolic blood pressure) compared to those without mutation. 8 The present case was caused by TSC gene homozygous mutations, which is consistent with the disease and has already been reported in a compound heterozygous case, 4 suggesting that this mutation is functionally critical.
Interestingly, this case of typical Gitelman's syndrome showed hypertension during middle age. The patient was obese and her mother had essential hypertension, so it is presumed that her blood pressure rise was caused by essential hypertension. Low blood pressure in patients with Gitelman's syndrome is relatively mild compared to that in Bartter's syndrome, and the decrease of sodium reabsorption in Gitelman's syndrome is not so severe. This may be the reason why hypertension occurred in the present patient with Gitelman's syndrome.
Essential hypertension is a multifactorial polygenic disease caused by gene-environmental interactions. 9 Many candidate genes have been reported, with significant differences in the polymorphisms of these genes. 10 The TSC gene is also a candidate gene for essential hypertension. 4, 11 However, the present case demonstrates that hypertension is able to be caused despite loss of TSC gene function and a sodiumlosing state, thus indicating that essential hypertension is genetically heterogeneous, and abnormality of all genes may not be necessarily required to cause the blood pressure rise. Further studies are needed to confirm this concept.
